Meeting
2023 ASCO Quality Care Symposium
Trends of cancer drug cost increases and impact of generic and biosimilar drug launches.
Authors
Puneeth Indurlal
The US Oncology Network, The Woodlands, TX
Puneeth Indurlal, Lalan S. Wilfong, Jody S. Garey, Leslie T. Busby, Erica Feinberg
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Survivorship
Sub Track
Cost and Cost-Effectiveness of Care
Citation
JCO Oncol Pract 19, 2023 (suppl 11; abstr 19)
DOI
10.1200/OP.2023.19.11_suppl.19
Abstract #
19
Poster Bd #
B2
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Cost of oral cancer drugs: Trends in the United States Medicare population in 2013 and 2015.
First Author: Kira Rose-Madison Seiger
Poster
2019 ASCO Annual Meeting
Quantification of the financial burden of antineoplastic agent price increases.
First Author: Michail Alevizakos
First Author: Jeddeo Paul
Poster
2024 ASCO Annual Meeting
Medicare reimbursement trends of biological reference agents and their biosimilars.
First Author: John Albaugh